Cadila Healthcare

Cadila Healthcare or Zydus Cadila – an India based pharmaceutical company having presence around the world.

Cadila Healthcare Ltd., under the aegis of the Zydus Group is set up in the year 1995 and have international presence in countries as -

  • Zydus Healthcare (USA) LLC, our subsidiary in the US.
  • Zydus Pharmaceuticals USA. Inc supplies finished dosage formulations to the US generic market.
  • Zydus France SAS France. With product basket of 90 generic registrations.
  • Zydus Healthcare Brasil Limitada , subsidiary in Brazil set up to market formulations.
The Cadila Healthcare group exports branded formulations to 43 countries around the worldwide. For growth in exports, Zydus Cadila has been focusing on introducing new molecules. Cadila Healthcare has 560 product registrations. Cadila Healthcare overall therapy segment is focused on cardiovasculars, gastrointestinals and pain management to drive growth in exports. The Cadila Healthcare group markets APIs to 40 countries worldwide.

Latest Financial Figures(Figures in Rs. Crores)
ET 500 Rank(2011)165
IndustryPharmaceuticals
Turnover4643.3
Profit after Tax(PAT)711
MCAP (Market Capitalization)15470.21
Assets3335.7

Activities:

Cadila Healthcare product portfolio covers areas like formulations, Active Pharmaceutical Ingredients (API), diagnostics, health & dietetic foods, skin care and animal health-care.

Cadila Healthcare core divisions includes -

  • Zydus Cadila.
  • Zydus Alidac.
  • Zydus Medica.
  • Zydus Biogen.
  • Zydus Neurosciences.
  • Zydus Vaccicare.
Cadila Healthcare products covers Therapeutic Segments like – Anti-Infective, Anti-Epileptic, Anti-Allergic, Anti-Depressant, Gastrointestinals, Anti-Osteoporosis, Sedative, Women's Healthcare, Anti-Rheumatic, Anti-Diabetic, Anti-Psychotic, Tranquilizers, Pain Management and Tadalafil.

Cadila Healthcare owns blockbuster brands like and its product line includes -

Oflin OD, Clodus, NeoLoridin, Ven-OD, Isbis, Bonmax, Cartup, Zyquin, Oxeptal, Zytonin, Cefinar, Zycolchin, Dactive, Vageston, Xet, Aldren, Serlin, Mexate, Epsolin, Euglim, Olandus, Divalpro, Topiram, Cytolog, Stilnite, Mifegest, Linid, Mosadac, Espra, Salazar, Lamidus, Zoldac and Zydalis.

Performance:

Cadila Healthcare has registered a turnover of ` 4211 million for the year ended 31st March 2007. Cadila Healthcare has posted Net Profit to the tune of ` 389 million for the year ended 31st March 2007.

Organization

Cadila Healthcare is headed by Mr Pankaj R. Patel , Chairman and Managing Director . Cadila Healthcare Corporate Headquarter is located at:

Zydus Tower,
Satellite Cross Roads,
Ahmedabad 380015.
India

Tel: 91-79-26868100
Fax: 91-79-26862366
Web site: www.zyduscadila.com

Last Updated on 1/4/2012

Alphabetical list of Companies